CD3 (Cancer Data Driven Detection) is a new, multidisciplinary and multi-institutional strategic national research programme dedicated to using data to transform our understanding of cancer risk and enable early interception of cancers.

It represents a major, multi-million-pound flagship investment funded through a strategic programme award by Cancer Research UK, the National Institute for Health and Care Research (NIHR) and the Engineering and Physical Sciences Research Council (EPSRC); in partnership with Health Data Research UK (HDR UK) and the Economic and Social Research Council’s Administrative Data Research UK programme (ADR UK).

Firmly guided by clinical and domain expertise and partnership with patients and public, the CD3 programme will greatly improve our understanding of who is most at risk of developing cancer and, hence, advance our ability to prevent, detect and diagnose cancers early in ways that are highly attentive to equity. This will be achieved by building an open and inclusive network of multidisciplinary researchers devoted to capitalising on the UK’s population-scale multimodal electronic health record, administrative and cohort infrastructure, and its distinctive strengths in cancer genomics, epidemiology and advanced analytics.

CD3: Cancer Data-Driven Detection

Org chart

Teams

Offices